Biogen Inc (BIIB)
Number of days of payables
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 12.10 | 11.93 | 15.04 | 13.95 | 13.74 | 12.35 | 11.13 | 10.00 | 10.29 | 15.48 | 13.91 | 15.10 | 9.62 | 8.94 | 8.29 | 5.63 | 3.97 | 4.42 | 4.54 | 4.65 | |
Number of days of payables | days | 30.18 | 30.60 | 24.27 | 26.16 | 26.56 | 29.57 | 32.79 | 36.52 | 35.46 | 23.58 | 26.23 | 24.18 | 37.96 | 40.81 | 44.05 | 64.81 | 91.98 | 82.55 | 80.42 | 78.54 |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 12.10
= 30.18
Biogen Inc's number of days of payables has shown a decreasing trend over the past years, indicating a more efficient management of its payables. The metric decreased from approximately 78.54 days as of March 31, 2020, to around 30.18 days as of December 31, 2024. This suggests that the company is taking fewer days to pay its creditors, potentially improving its cash flow and liquidity position. The declining trend in days of payables could also imply better negotiation power with suppliers or improved working capital management. Additionally, a lower number of days of payables may indicate a more effective supply chain management strategy. It will be essential to monitor this ratio in future periods to assess the ongoing effectiveness of Biogen Inc's payables management.
Peer comparison
Dec 31, 2024